The first evidence that removing amyloid plaques may delay Alzheimer’s symptoms has now been published. In The Lancet Neurology on March 19, scientists led by Randall Bateman at Washington University ...

Like lecanemab before it, donanemab’s path to market has been slow and rocky. In the U.S., the antibody received Food and ...

Dysfunctional Family. A family tree of tau folds now incorporates two new structures—P301L, P301T (bottom)—and fills in ...

Do you know a conference you think we should list? Let us know by sending us an email with the details to [email protected].

It is dedicated to the study of epilepsy and Sudden Death in Epilepsy (SUDEP), providing brain and other tissue samples to researchers for ethically approved epilepsy research. Such research can help ...

Lillian Fry, B.A., M.L.S.

Susan Vergeront , B.S., M. Div. Sun Prairie, United States ...

Kim Beckett, B.B.A., J.D. Dallas, United States ...

Cognitive slippage is a normal part of aging, but what distinguishes this inevitable slowdown from the type of decline that foreshadows neurodegenerative disease? And might remote, digital ...

As the baby boom generation reaches its hopefully golden years, scientists have been projecting a doubling of dementia cases in the U.S. by 2050, alarming health care agencies, the public, and health ...

Already have an account? Log in.